MS Is Becoming a Milder Disease in the Near Future, Enabling a Normal Life

High efficacy used early is probably a major block against late disability emphasizes Patricia K. Coyle, Professor at Stony Brook University MS Comprehensive Care Center, New York, in this MEDtalk from ACTRIMS 2025. She explains why she thinks that MS can be changed into a milder disease where the patients can expect that they are going to be able to live a normal life.